Effect of tetrahydrocurcumin on lipid peroxidation and lipids in streptozotocin-nicotinamide-induced diabetic rats
- PMID: 16918712
- DOI: 10.1111/j.1742-7843.2006.pto_447.x
Effect of tetrahydrocurcumin on lipid peroxidation and lipids in streptozotocin-nicotinamide-induced diabetic rats
Abstract
Hyperlipidaemia is an associated complication of diabetes mellitus. We recently reported that tetrahydrocurcumin lowered the blood glucose in diabetic rats. In the present study, we have investigated the effect of tetrahydrocurcumin, one of the active metabolites of curcumin on lipid profile and lipid peroxidation in streptozotocin-nicotinamide-induced diabetic rats. Tetrahydrocurcumin 80 mg/kg body weight was administered orally to diabetic rats for 45 days, resulted a significant reduction in blood glucose and significant increase in plasma insulin in diabetic rats, which proved its antidiabetic effect. Tetrahydrocurcumin also caused a significant reduction in lipid peroxidation (thiobarbituric acid reactive substances and hydroperoxides) and lipids (cholesterol, triglycerides, free fatty acids and phospholipids) in serum and tissues, suggesting its role in protection against lipid peroxidation and its antihyperlipidemic effect. Tetrahydrocurcumin showed a better effect when compared with curcumin. Results of the present study indicate that tetrahydrocurcumin showed antihyperlipidaemic effect in addition to its antidiabetic effect in type 2 diabetic rats.
Similar articles
-
Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats.Ren Fail. 2007;29(7):881-9. doi: 10.1080/08860220701540326. Ren Fail. 2007. PMID: 17994458
-
Antioxidant effect of tetrahydrocurcumin in streptozotocin-nicotinamide induced diabetic rats.Life Sci. 2006 Sep 27;79(18):1720-8. doi: 10.1016/j.lfs.2006.06.001. Epub 2006 Jun 9. Life Sci. 2006. PMID: 16806281
-
Effect of tetrahydrocurcumin on plasma antioxidants in streptozotocin-nicotinamide experimental diabetes.J Basic Clin Physiol Pharmacol. 2006;17(4):231-44. doi: 10.1515/jbcpp.2006.17.4.231. J Basic Clin Physiol Pharmacol. 2006. PMID: 17338279
-
Modulating efficacy of Rebaudioside A, a diterpenoid on antioxidant and circulatory lipids in experimental diabetic rats.Environ Toxicol Pharmacol. 2013 Sep;36(2):472-483. doi: 10.1016/j.etap.2013.05.009. Epub 2013 Jun 3. Environ Toxicol Pharmacol. 2013. PMID: 23792234
-
Tetrahydrocurcumin prevents brain lipid peroxidation in streptozotocin-induced diabetic rats.J Med Food. 2007 Jun;10(2):323-9. doi: 10.1089/jmf.2006.058. J Med Food. 2007. PMID: 17651069
Cited by
-
Statistical optimization of tetrahydrocurcumin loaded solid lipid nanoparticles using Box Behnken design in the management of streptozotocin-induced diabetes mellitus.Saudi Pharm J. 2023 Sep;31(9):101727. doi: 10.1016/j.jsps.2023.101727. Epub 2023 Aug 2. Saudi Pharm J. 2023. PMID: 37638219 Free PMC article.
-
Tetrahydrocurcumin-Related Vascular Protection: An Overview of the Findings from Animal Disease Models.Molecules. 2022 Aug 10;27(16):5100. doi: 10.3390/molecules27165100. Molecules. 2022. PMID: 36014335 Free PMC article. Review.
-
3D-Printed Mucoadhesive Collagen Scaffolds as a Local Tetrahydrocurcumin Delivery System.Pharmaceutics. 2021 Oct 15;13(10):1697. doi: 10.3390/pharmaceutics13101697. Pharmaceutics. 2021. PMID: 34683989 Free PMC article.
-
Obstacles against the Marketing of Curcumin as a Drug.Int J Mol Sci. 2020 Sep 10;21(18):6619. doi: 10.3390/ijms21186619. Int J Mol Sci. 2020. PMID: 32927725 Free PMC article. Review.
-
Spice-Derived Bioactive Ingredients: Potential Agents or Food Adjuvant in the Management of Diabetes Mellitus.Front Pharmacol. 2018 Aug 22;9:893. doi: 10.3389/fphar.2018.00893. eCollection 2018. Front Pharmacol. 2018. PMID: 30186162 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
